Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 50 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Azzouz B, Morel A, Kanagaratman L, Herlem E, Trenque T. Psoriasis after exposure to angiotensin-converting enzyme inhibitors: French pharmacovigilance data and review of the literature. Drug Saf 2019;42:diciembre. [Ref.ID 103209]
2.Enlace a cita original Cita con resumen
Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims. PLOS Medicine 2019:13 de marzo. [Ref.ID 103076]
3.
Arroll B, Doughty R, Andersen V. Investigation and management of congestive heart failure. BMJ 2010;341:190-5. [Ref.ID 88929]
4.Enlace a cita original
Bonet Monné S. Dades d'eficàcia dels IECA, ARA II i la combinació d'ambdós grups de fàrmacs. Butlletí d'Informació Terapèutica 2010;22:7-12. [Ref.ID 88270]
5. Cita con resumen
Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Golf Jr DC. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension. Results from the Cardiovascular Health Study. Arch Intern Med 2009;169:1195-202. [Ref.ID 86332]
6. Cita con resumen
Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J, for the Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008;135:1924-34. [Ref.ID 84961]
7.Tiene citas relacionadas Cita con resumen
Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 2008;148:16-29. [Ref.ID 81943]
8.
LeBlanc JM, Dasta JF, Pruchnicki MC, Schentag JJ. Impact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors. J Clin Pharmacol 2006;46:968-80. [Ref.ID 78008]
9.
Momma K. ACE Inhibitors in pediatric patients with heart failure. Pediatr Drugs 2006;8:55-69. [Ref.ID 76688]
10. Cita con resumen
Anónimo. New Zealand's prescription volumes increase by 10%. Scrip 2005;3115:20. [Ref.ID 75701]
11.
Ross S, Macleod MJ. Antihypertensive drug prescribing in Grampian. Br J Clin Pharmacol 2005;60:300-5. [Ref.ID 74717]
12.Tiene citas relacionadas
Hennessy S, Kimmel PL. Is improved survival a class effect of angiotensin-converting enzyme inhibitors?. Ann Intern Med 2004;141:157-8. [Ref.ID 71010]
13.Tiene citas relacionadas Cita con resumen
Pilote L, Abrahamowicz M, Rodrigues E, Eisenberg MJ, Rahme E. Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?. Ann Intern Med 2004;141:102-12. [Ref.ID 71005]
14. Cita con resumen
Anónimo. Actualització en el maneig del pacient amb insuficiència cardíaca. Butlletí d'Informació Farmacoterapèutica Regió Sanitària Girona 2004;42:1-8. [Ref.ID 70845]
15. Cita con resumen
Anónimo. A wave of new generics in the UK. Scrip 2004;2948:2. [Ref.ID 70012]
16. Cita con resumen
Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use. Arch Intern Med 2004;164:910-3. [Ref.ID 69945]
17.
Thilly N, Zannad F, Dufay E, Juillière Y, Briançon S. Elaboration de recommandations de pratique clinique: les inhibiteurs de l'enzyme de conversion dans l'insuffisance cardiaque. Therapie 2003;58:341-9. [Ref.ID 67899]
18. Cita con resumen
19. Cita con resumen
Jacoby DS, Rader D J. Renin-angiotensin system and atherothrombotic disease. From genes to treatment. Arch Intern Med 2003;163:1155-64. [Ref.ID 66378]
20.
Hemels MEH, Bennett HA, Bonari L, Han D, Traverso ML, Einarson TR. HOPE Study impact on ACE inhibitors use. Ann Pharmacother 2003;37:640-5. [Ref.ID 65934]
Seleccionar todas
 
 1 a 20 de 50 siguiente >>